Cargando…

Differential Binding of Autoantibodies to MOG Isoforms in Inflammatory Demyelinating Diseases

OBJECTIVE: To analyze serum immunoglobulin G (IgG) antibodies to major isoforms of myelin oligodendrocyte glycoprotein (MOG-alpha 1-3 and beta 1-3) in patients with inflammatory demyelinating diseases. METHODS: Retrospective case-control study using 378 serum samples from patients with multiple scle...

Descripción completa

Detalles Bibliográficos
Autores principales:	Schanda, Kathrin, Peschl, Patrick, Lerch, Magdalena, Seebacher, Barbara, Mindorf, Swantje, Ritter, Nora, Probst, Monika, Hegen, Harald, Di Pauli, Franziska, Wendel, Eva-Maria, Lechner, Christian, Baumann, Matthias, Mariotto, Sara, Ferrari, Sergio, Saiz, Albert, Farrell, Michael, Leite, Maria Isabel S., Irani, Sarosh R., Palace, Jacqueline, Lutterotti, Andreas, Kümpfel, Tania, Vukusic, Sandra, Marignier, Romain, Waters, Patrick, Rostasy, Kevin, Berger, Thomas, Probst, Christian, Höftberger, Romana, Reindl, Markus
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Lippincott Williams & Wilkins 2021
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8207634/ https://www.ncbi.nlm.nih.gov/pubmed/34131067 http://dx.doi.org/10.1212/NXI.0000000000001027

Ejemplares similares

International multicenter examination of MOG antibody assays
por: Reindl, Markus, et al.
Publicado: (2020)

MOG antibody seropositivity in a patient with encephalitis: beyond the classical syndrome
por: Mariotto, Sara, et al.
Publicado: (2017)

More Efficient Complement Activation by Anti–Aquaporin-4 Compared With Anti–Myelin Oligodendrocyte Glycoprotein Antibodies
por: Lerch, Magdalena, et al.
Publicado: (2022)

Human antibodies against the myelin oligodendrocyte glycoprotein can cause complement-dependent demyelination
por: Peschl, Patrick, et al.
Publicado: (2017)

MOG antibody-associated diseases
por: Reindl, Markus, et al.
Publicado: (2015)

Comparison of Diagnostic Accuracy of Microscopy and Flow Cytometry in Evaluating N-Methyl-D-Aspartate Receptor Antibodies in Serum Using a Live Cell-Based Assay
por: Ramberger, Melanie, et al.
Publicado: (2015)

Frequency of MOG-IgG in cerebrospinal fluid versus serum
por: Pace, Samuel, et al.
Publicado: (2022)

Methodological Challenges in Protein Microarray and Immunohistochemistry for the Discovery of Novel Autoantibodies in Paediatric Acute Disseminated Encephalomyelitis
por: Peschl, Patrick, et al.
Publicado: (2017)

Recent developments in MOG-IgG associated neurological disorders
por: Hegen, Harald, et al.
Publicado: (2020)

Increased peripheral inflammatory responses in myelin oligodendrocyte glycoprotein associated disease and aquaporin-4 antibody positive neuromyelitis optica spectrum disorder
por: Bauer, Angelika, et al.
Publicado: (2022)

Antibodies to aquaporin-1 are not present in neuromyelitis optica
por: Schanda, Kathrin, et al.
Publicado: (2015)

Clinical and imaging features of children with autoimmune encephalitis and MOG antibodies
por: Wegener-Panzer, Andreas, et al.
Publicado: (2020)

Serum MOG IgG titres should be performed routinely in the diagnosis and follow-up of MOGAD: Yes
por: Reindl, Markus, et al.
Publicado: (2023)

NMDA receptor antibodies: A rare association in inflammatory demyelinating diseases
por: Ramberger, Melanie, et al.
Publicado: (2015)

Myelin Oligodendrocyte Glycoprotein: Deciphering a Target in Inflammatory Demyelinating Diseases
por: Peschl, Patrick, et al.
Publicado: (2017)

Intracellular and non-neuronal targets of voltage-gated potassium channel complex antibodies
por: Lang, Bethan, et al.
Publicado: (2017)

Cerebrospinal fluid findings in patients with myelin oligodendrocyte glycoprotein (MOG) antibodies. Part 1: Results from 163 lumbar punctures in 100 adult patients
por: Jarius, Sven, et al.
Publicado: (2020)

Cranial nerve involvement in patients with MOG antibody–associated disease
por: Cobo-Calvo, Alvaro, et al.
Publicado: (2019)

Epidemiology of Pediatric NMOSD in Germany and Austria
por: Lechner, Christian, et al.
Publicado: (2020)

MOG encephalomyelitis: international recommendations on diagnosis and antibody testing
por: Jarius, S., et al.
Publicado: (2018)

Humoral signatures of MOG-antibody-associated disease track with age and disease activity
por: Spatola, Marianna, et al.
Publicado: (2023)

Is there a correlation between MOG‐associated disorder and SARS‐CoV‐2 infection?
por: Mariotto, Sara, et al.
Publicado: (2022)

Anti-NMDA receptor encephalitis and MOG-associated demyelination – a case report with long-term follow-up and a systematic review
por: Berek, Klaus, et al.
Publicado: (2022)

Temporal Dynamics of MOG Antibodies in Children With Acquired Demyelinating Syndrome
por: Wendel, Eva Maria, et al.
Publicado: (2022)

MOG-expressing teratoma followed by MOG-IgG-positive optic neuritis
por: Wildemann, Brigitte, et al.
Publicado: (2020)

Comparative Analysis of T-Cell Responses to Aquaporin-4 and Myelin Oligodendrocyte Glycoprotein in Inflammatory Demyelinating Central Nervous System Diseases
por: Hofer, Livia Sophie, et al.
Publicado: (2020)

ADEM-like presentation, anti-MOG antibodies, and MS pathology: TWO case reports
por: Körtvélyessy, Peter, et al.
Publicado: (2017)

Cerebrospinal fluid findings in patients with myelin oligodendrocyte glycoprotein (MOG) antibodies. Part 2: Results from 108 lumbar punctures in 80 pediatric patients
por: Jarius, Sven, et al.
Publicado: (2020)

A multicenter comparison of MOG-IgG cell-based assays
por: Waters, Patrick J., et al.
Publicado: (2019)

Identification of circulating MOG-specific B cells in patients with MOG antibodies
por: Winklmeier, Stephan, et al.
Publicado: (2019)

Evaluation of treatment response in adults with relapsing MOG-Ab-associated disease
por: Cobo-Calvo, Alvaro, et al.
Publicado: (2019)

Rituximab-Induced Hypogammaglobulinemia and Infections in AQP4 and MOG Antibody–Associated Diseases
por: Avouac, Alexandre, et al.
Publicado: (2021)

MOG cell-based assay detects non-MS patients with inflammatory neurologic disease
por: Waters, Patrick, et al.
Publicado: (2015)

Editorial on EJPN focus section on E.U. paediatric MOG consortium consensus statements
por: Neuteboom, R.F., et al.
Publicado: (2020)

Overlapping central and peripheral nervous system syndromes in MOG antibody–associated disorders
por: Rinaldi, Simon, et al.
Publicado: (2020)

Basic CSF parameters and MRZ reaction help in differentiating MOG antibody-associated autoimmune disease versus multiple sclerosis
por: Vlad, Benjamin, et al.
Publicado: (2023)

A Fulminant Case of Demyelinating Encephalitis With Extensive Cortical Involvement Associated With Anti-MOG Antibodies
por: Hochmeister, Sonja, et al.
Publicado: (2020)

Evaluation of brain lesion distribution criteria at disease onset in differentiating MS from NMOSD and MOG-IgG-associated encephalomyelitis
por: Hyun, Jae-Won, et al.
Publicado: (2018)

Complement activating antibodies to myelin oligodendrocyte glycoprotein in neuromyelitis optica and related disorders
por: Mader, Simone, et al.
Publicado: (2011)

Investigating the association between neoplasms and MOG antibody-associated disease
por: Trentinaglia, Milena, et al.
Publicado: (2023)

Cannot write session to /tmp/vufind_sessions/sess_k6ikk9k0gklqq3pnhtsbikefef